JNJ shares hold above key moving averages supported by firm ADX reading: weekly report

Traders Union
All News
Financial News
Johnson & Johnson slips 1.00% this week

Highlights

Johnson & Johnson faces short-term selling pressure but maintains a medium- and long-term bullish technical structure above key support levels.
Momentum indicators show a positive bias, while oversold signals from oscillators suggest potential for a near-term rebound after recent declines.
Expected trading range is $232.36 to $235.98 with a 75% probability of an upward move, contingent on holding above $224 support.

Litigation setbacks and dividend appeal drive sentiment over the week

Recent legal developments saw Johnson & Johnson's third attempt to resolve talcum powder liability through Chapter 11 bankruptcy dismissed, impacting the landscape for outstanding litigation related to talc claims. The company also drew renewed attention as one of the 10 Best Quality Dividend Stocks to Buy According to Reddit, reflecting investor interest in its established healthcare presence. These factors continue to shape sentiment and outlook for the stock.

Bullish momentum holds as oversold signals test support in weekly trade

On the weekly timeframe, JNJ has experienced a decline to the lower end of its W1 range, with volatility at 3.14%. The price is pressed just below the weekly MA-20 ($229.79) and close to dynamic support in the $218.42 to $229.79 area, while remaining firmly above the MA-50 and MA-200. Weekly momentum indicators are broadly positive: MACD signals a Strong Buy, ADX is at 35.74 (Buy), and RSI reads 55.21 (Buy). However, Stochastic RSI and Bull/Bear Power both show oversold readings (Stochastic RSI: Oversold; Bull/Bear Power: -1.28), suggesting persistent near-term selling. The Commodity Channel Index and Awesome Oscillator remain neutral. Weekly support is seen at $224 and $218, while resistance is layered at $232.36 and $235.98.

Stabilization likely next week as bullish bias meets oversold risks

Over the next 5 trading days, JNJ is expected to consolidate above current support around the MA-20, with a projected range between $232.36 and $235.98, and an average price near $234.17. There is a 75% probability of an upward move as 3 out of 4 key weekly indicators remain bullish, although the oversold conditions point to a potential for sideways consolidation before any sustained rebound. A break above $236 could trigger a bullish scenario towards previous weekly highs, while a drop below $224 would suggest a short-term test of lower levels. The baseline scenario favors stabilization or modest recovery, supported by underlying momentum.

Earlier, analysts noted that despite short-term volatility, Johnson & Johnson’s longer-term technical and fundamental outlook remained constructive. This latest analysis adds the dimension of renewed legal uncertainty and continued oversold readings, highlighting the importance of monitoring support at $224 and the potential for sideways consolidation before any sustained move.

Source of Data: JNJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.